1. Home
  2. UBX vs NYC Comparison

UBX vs NYC Comparison

Compare UBX & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • NYC
  • Stock Information
  • Founded
  • UBX 2009
  • NYC 2013
  • Country
  • UBX United States
  • NYC United States
  • Employees
  • UBX N/A
  • NYC N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • NYC Real Estate
  • Sector
  • UBX Health Care
  • NYC Finance
  • Exchange
  • UBX Nasdaq
  • NYC Nasdaq
  • Market Cap
  • UBX 24.6M
  • NYC 23.8M
  • IPO Year
  • UBX 2018
  • NYC N/A
  • Fundamental
  • Price
  • UBX $1.00
  • NYC $8.51
  • Analyst Decision
  • UBX Strong Buy
  • NYC
  • Analyst Count
  • UBX 1
  • NYC 0
  • Target Price
  • UBX $8.00
  • NYC N/A
  • AVG Volume (30 Days)
  • UBX 82.0K
  • NYC 3.3K
  • Earning Date
  • UBX 11-04-2024
  • NYC 11-12-2024
  • Dividend Yield
  • UBX N/A
  • NYC N/A
  • EPS Growth
  • UBX N/A
  • NYC N/A
  • EPS
  • UBX N/A
  • NYC N/A
  • Revenue
  • UBX N/A
  • NYC $62,060,000.00
  • Revenue This Year
  • UBX N/A
  • NYC N/A
  • Revenue Next Year
  • UBX $33.62
  • NYC $3.18
  • P/E Ratio
  • UBX N/A
  • NYC N/A
  • Revenue Growth
  • UBX N/A
  • NYC N/A
  • 52 Week Low
  • UBX $1.00
  • NYC $5.46
  • 52 Week High
  • UBX $2.02
  • NYC $10.91
  • Technical
  • Relative Strength Index (RSI)
  • UBX 28.85
  • NYC 47.19
  • Support Level
  • UBX $1.10
  • NYC $7.96
  • Resistance Level
  • UBX $1.23
  • NYC $9.15
  • Average True Range (ATR)
  • UBX 0.06
  • NYC 0.50
  • MACD
  • UBX -0.01
  • NYC 0.05
  • Stochastic Oscillator
  • UBX 0.00
  • NYC 49.21

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About NYC American Strategic Investment Co.

American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.

Share on Social Networks: